Industry Insights Logo

Webinar —Behind the Headlines: A 340B Insider Briefing with Ted Slafsky

SPONSORED CONTENT

Stay ahead of the latest developments shaping the 340B landscape with Ted Slafsky, Publisher and CEO of 340B Report. In this special, hour-long insider briefing, Ted will share timely insights, important context, and practical takeaways on the policy shifts and

Read More »
Industry Insights Logo

Safeguarding Your 340B Program

SPONSORED CONTENT

Introduction: Navigating Political Headwinds

As the 2025 political season heats up, federally qualified health centers (FQHCs), hospitals, STD clinics, Ryan White grantees, and other covered entities must brace for another round of uncertainty. With renewed debates around entitlement

Read More »
Industry Insights Logo

Navigating the Complexities of Specialty Medication Claims Processing

SPONSORED CONTENT

The term “specialty medication” is often associated with a hefty price tag and numerous challenges related to claims processing. While this may be true in certain circumstances, organizations providing or considering offering specialty medications can still successfully navigate these complexities with

Read More »
Industry Insights Logo

Should We Prepare for a 340B Rebate Model?

SPONSORED CONTENT

As we endure Spring 2025, many covered entities (CEs) continue to perform their ordinary and necessary duties to operate their 340B programs.  This may include conducting an annual independent audit, financially reconciling the previous fiscal year, getting

Read More »
Industry Insights Logo

Effective Contract Pharmacy Strategies in an Ever-Changing Landscape

SPONSORED CONTENT

W. Edwards Deming is a renowned statistician and expert in quality management. He is often quoted as saying, “Uncontrolled variation is the enemy of quality.” In the realm of 340B, including 340B contract pharmacies, that change is both continual and constant.

Read More »
Industry Insights Logo

Setting the Record Straight

SPONSORED CONTENT

The 340B program has come under increased scrutiny within the past five years. Opponents often claim it is misused by covered entities (CEs) to generate profits rather than help vulnerable patients. These criticisms often come from a misunderstanding of

Read More »
Industry Insights Logo

How to Maximize Partner Support for Referral Capture During a HRSA Audit

SPONSORED CONTENT

A HRSA audit is not a question of if but when. Therefore, it is crucial for covered entities (CEs) to always remain audit-ready. The 340B program has become increasingly complex over the years, prompting service provider partners (partners) in the

Read More »
Industry Insights Logo

Navigating Uncertainty: Reflections from the 340B Coalition Winter Conference 

SPONSORED CONTENT

Let me start by saying that I have been to the 340B Coalition conferences since 2012, and every year entities have feared significant changes and the threat of problematic legislation becoming law. Fortunately,

Read More »
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
×

*Sign up for news summaries and alerts from 340B Report

Site Footer Live